100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached 4.2 TrustPilot
logo-home
Exam (elaborations)

REGIS NU 641 CLINICAL ADV PHARMACOLOGY FINAL EXAM

Rating
-
Sold
-
Pages
5
Grade
A+
Uploaded on
12-10-2024
Written in
2024/2025

REGIS NU 641 CLINICAL ADV PHARMACOLOGY FINAL EXAM

Institution
Course









Whoops! We can’t load your doc right now. Try again or contact support.

Connected book

Written for

Course

Document information

Uploaded on
October 12, 2024
Number of pages
5
Written in
2024/2025
Type
Exam (elaborations)
Contains
Questions & answers

Subjects

Content preview

REGIS NU 641 CLINICAL ADV PHARMACOLOGY FINAL
EXAM ACTUAL EXAM 100 QUESTIONS AND CORRECT
DETAILED ANSWERS|ALREADY GRADED A
hyperlipidemia - ANSWER: high cholesterol levels in the blood, which can lead to
heart dz, stroke and other problems caused by block arteries

Atherosclerosis - ANSWER: Changes in the walls of large arteries consisting of lipid
deposits on the artery walls, which incidences can be reduced with proper treatment
of hyperlipidemia

Treatment goal of hyperlipidemia - ANSWER: lowering of the cholesterol to
appropriate levels to decrease the risk of heart attack and stroke

Non-pharmacology treatment - ANSWER: Therapeutic Lifestyle Changes (TLC)
important part of treatment and are not futile

Pharmacology - ANSWER: Medications

Statins - ANSWER: lower cholesterol in the blood and reduce its production in the
liver by blocking the enzyme that produces it; has adverse effects that can occur
more frequently at higher doses.

LDL cholesterol - ANSWER: goal of < 70 in high risk patients
goal of < 100 in mod high-risk patients

DM pts w/ acute coronary artery syndrome & multiple or uncontrolled risk factors;
Tx = - ANSWER: TLC, changes in diet restrict refined carbs (sugar & liquid calories),
wgt loss (pt will not be able to participate in aerobic activity if had previous MI),
decreased insulin resistance, decreased BP, improved cardiovascular conditioning,
limit/ restrict ETOH consumption.

Which patients are easier to manage? - ANSWER: Patients at low risk for developing
heart dz.

What med is recommended if the LDL cannot be decreased by a high dose of potent
statin? - ANSWER: Nicotinic acid

Med combination to lower triglycerides and increase the HDL - ANSWER: a
fibrate/nicotinic acid with statin

Patient Education for Statin - ANSWER: Pt to report report extreme fatigue, darked-
color urine, ck elevated, rhabdomylitis (muscle aches); if reported stop immediately
and check LFT(Liver Fxn Test)

, lescol (Statin) - ANSWER: This med can affect liver function and increase liver
enzymes as well cause the pt to feel weak, fatigue and have muscle aches checking
the LFT is recommended

Acute drug induced hepatitis - ANSWER: the Liver enzymes are elevated w/ the use
of statin

If pt has acute and chronic hepatitis, liver disease cirrhosis and alcoholism; or
pregnant/breastfeeding mothers - ANSWER: DO NOT PRESCRIBE STATINS

First-line therapy for hyperlipidemia - ANSWER: Therapeutic Life Changes (TLC) Such
as: balanced diet, weight loss, minimize risk factors before medications

Which drug class is most effective for the management of hyperlipidemia with
concurrent elevated triglycerides (TGs)? - ANSWER: Fibrates

How do you identify the potential serious adverse drug reactions with
hyperlipidemia agents? - ANSWER: Monitor BP within 1 to 3 hours of administration
to check for hypotensive affect

What type of counseling would you give to a pt who just started on hyperlipidemia
agents, such as an HMG Co-A reductase inhibitor (statin), etc? - ANSWER: myopathy
and hepatatoxicity

What is the second line treatment options if a patient fails a statin? - ANSWER: Bile
acid-binding resins

Patient factors which preclude use of an HMG Co-A reductase inhibitor - ANSWER:
*patients with active hepatic disease or unexplained persistent elevations in
aminotransferase levels
* in pregnancy and during breastfeeding as cholesterol is an essential component for
fetal and infant synthesis of steroids and cell membrane development
*caution is necessary for patients with already increased blood glucose *levels or
increased Hba1c levels.
can increase the risk of statin-induced myopathy

Which hyperlipidemia agents are appropriate for use in pregnancy with respect to
risk to fetus as well as mother? - ANSWER: Fibrates

Which drug (statin) decrease LDL at a greatest percentage? - ANSWER: Rosuvastatin

Post MI dose of ASA - ANSWER: BMI > 29 = 325mg ASA
BMI < 29 = 81mg ASA (low dose)

heart failure (HF) - ANSWER: A condition in which the heart fails to discharge its
contents adequately; affects the cardiovascular, musculoskeletal, renal and
neuroendocrine systems
$17.99
Get access to the full document:

100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached

Get to know the seller
Seller avatar
morrismuriithi009
3.0
(1)

Get to know the seller

Seller avatar
morrismuriithi009 Teachme2-tutor
Follow You need to be logged in order to follow users or courses
Sold
1
Member since
1 year
Number of followers
0
Documents
760
Last sold
3 weeks ago

3.0

1 reviews

5
0
4
0
3
1
2
0
1
0

Recently viewed by you

Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Frequently asked questions